GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxj3
|
ENSMUSG00000032998.10 | forkhead box J3 |
Tbl1xr1
|
ENSMUSG00000027630.8 | transducin (beta)-like 1X-linked receptor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxj3 | mm10_v2_chr4_+_119539652_119539698 | 0.79 | 7.3e-09 | Click! |
Tbl1xr1 | mm10_v2_chr3_+_22076644_22076681 | 0.62 | 6.3e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_54422286 | 20.82 |
ENSMUST00000181269.1
|
Redrum
|
Redrum, erythroid developmental long intergenic non-protein coding transcript |
chr1_+_174172738 | 20.70 |
ENSMUST00000027817.7
|
Spta1
|
spectrin alpha, erythrocytic 1 |
chr11_-_55185029 | 16.35 |
ENSMUST00000039305.5
|
Slc36a2
|
solute carrier family 36 (proton/amino acid symporter), member 2 |
chr16_+_36184082 | 16.33 |
ENSMUST00000114858.1
|
Gm5483
|
predicted gene 5483 |
chr4_+_134864536 | 14.69 |
ENSMUST00000030627.7
|
Rhd
|
Rh blood group, D antigen |
chr6_-_41704339 | 14.18 |
ENSMUST00000031899.8
|
Kel
|
Kell blood group |
chr3_-_106167564 | 13.40 |
ENSMUST00000063062.8
|
Chi3l3
|
chitinase 3-like 3 |
chr7_-_100514800 | 13.26 |
ENSMUST00000054923.7
|
Dnajb13
|
DnaJ (Hsp40) related, subfamily B, member 13 |
chr10_+_79886302 | 12.57 |
ENSMUST00000046091.5
|
Elane
|
elastase, neutrophil expressed |
chrX_-_7964166 | 12.41 |
ENSMUST00000128449.1
|
Gata1
|
GATA binding protein 1 |
chr8_+_23035099 | 12.28 |
ENSMUST00000117662.1
|
Ank1
|
ankyrin 1, erythroid |
chr10_-_111997204 | 11.47 |
ENSMUST00000074805.5
|
Glipr1
|
GLI pathogenesis-related 1 (glioma) |
chr11_-_83286722 | 11.15 |
ENSMUST00000163961.2
|
Slfn14
|
schlafen family member 14 |
chr2_+_84988194 | 10.82 |
ENSMUST00000028466.5
|
Prg3
|
proteoglycan 3 |
chr10_+_79879614 | 10.47 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chrX_+_8271381 | 10.35 |
ENSMUST00000033512.4
|
Slc38a5
|
solute carrier family 38, member 5 |
chr3_-_90695706 | 10.17 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr19_-_11640828 | 10.02 |
ENSMUST00000112984.2
|
Ms4a3
|
membrane-spanning 4-domains, subfamily A, member 3 |
chr1_+_40515362 | 9.58 |
ENSMUST00000027237.5
|
Il18rap
|
interleukin 18 receptor accessory protein |
chr8_+_23035116 | 9.54 |
ENSMUST00000117296.1
ENSMUST00000141784.2 |
Ank1
|
ankyrin 1, erythroid |
chr13_-_19824234 | 9.47 |
ENSMUST00000065335.2
|
Gpr141
|
G protein-coupled receptor 141 |
chr16_+_36253046 | 9.38 |
ENSMUST00000063539.6
|
2010005H15Rik
|
RIKEN cDNA 2010005H15 gene |
chr16_+_36277145 | 9.22 |
ENSMUST00000042097.9
|
Stfa1
|
stefin A1 |
chr11_-_69617879 | 9.03 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr6_-_115762346 | 9.02 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr8_+_57455898 | 8.84 |
ENSMUST00000034023.3
|
Scrg1
|
scrapie responsive gene 1 |
chr9_+_7558429 | 8.77 |
ENSMUST00000018765.2
|
Mmp8
|
matrix metallopeptidase 8 |
chr1_+_107535508 | 8.74 |
ENSMUST00000182198.1
|
Serpinb10
|
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 10 |
chr2_-_28621932 | 8.73 |
ENSMUST00000028156.7
ENSMUST00000164290.1 |
Gfi1b
|
growth factor independent 1B |
chr11_-_53480178 | 8.57 |
ENSMUST00000104955.2
|
Sowaha
|
sosondowah ankyrin repeat domain family member A |
chr14_+_80000292 | 8.46 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr11_-_99438143 | 8.33 |
ENSMUST00000017743.2
|
Krt20
|
keratin 20 |
chr6_+_134929089 | 8.23 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr9_+_111019284 | 8.06 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr13_-_37050237 | 8.04 |
ENSMUST00000164727.1
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr7_-_13837410 | 8.03 |
ENSMUST00000108522.3
|
Sult2a1
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
chr1_+_136467958 | 7.98 |
ENSMUST00000047817.6
|
Kif14
|
kinesin family member 14 |
chr7_-_103843154 | 7.92 |
ENSMUST00000063957.4
|
Hbb-bh1
|
hemoglobin Z, beta-like embryonic chain |
chr16_+_45610380 | 7.87 |
ENSMUST00000161347.2
ENSMUST00000023339.4 |
Gcsam
|
germinal center associated, signaling and motility |
chr11_+_58640394 | 7.83 |
ENSMUST00000075084.4
|
Trim58
|
tripartite motif-containing 58 |
chr14_-_56102458 | 7.82 |
ENSMUST00000015583.1
|
Ctsg
|
cathepsin G |
chr17_+_40811089 | 7.81 |
ENSMUST00000024721.7
|
Rhag
|
Rhesus blood group-associated A glycoprotein |
chrX_+_8271133 | 7.78 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chrX_+_93654863 | 7.63 |
ENSMUST00000113933.2
|
Pcyt1b
|
phosphate cytidylyltransferase 1, choline, beta isoform |
chr2_-_121037048 | 7.62 |
ENSMUST00000102490.3
|
Epb4.2
|
erythrocyte protein band 4.2 |
chr14_-_60197173 | 7.58 |
ENSMUST00000131670.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr5_+_90490714 | 7.56 |
ENSMUST00000042755.3
|
Afp
|
alpha fetoprotein |
chrX_-_136203637 | 7.53 |
ENSMUST00000151592.1
ENSMUST00000131510.1 ENSMUST00000066819.4 |
Tceal5
|
transcription elongation factor A (SII)-like 5 |
chr8_-_85365317 | 7.52 |
ENSMUST00000034133.7
|
Mylk3
|
myosin light chain kinase 3 |
chr19_-_20390944 | 7.49 |
ENSMUST00000025561.7
|
Anxa1
|
annexin A1 |
chr10_-_80813486 | 7.44 |
ENSMUST00000181039.1
ENSMUST00000180438.1 |
Jsrp1
|
junctional sarcoplasmic reticulum protein 1 |
chr16_-_36408349 | 7.39 |
ENSMUST00000023619.6
|
Stfa2
|
stefin A2 |
chr17_+_48232755 | 7.33 |
ENSMUST00000113251.3
ENSMUST00000048782.6 |
Trem1
|
triggering receptor expressed on myeloid cells 1 |
chr1_-_144775419 | 7.33 |
ENSMUST00000027603.3
|
Rgs18
|
regulator of G-protein signaling 18 |
chr7_+_13733502 | 7.31 |
ENSMUST00000086148.6
|
Sult2a2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
chr4_-_46404224 | 7.29 |
ENSMUST00000107764.2
|
Hemgn
|
hemogen |
chr5_-_108749448 | 7.27 |
ENSMUST00000068946.7
|
Rnf212
|
ring finger protein 212 |
chr15_+_79895017 | 7.06 |
ENSMUST00000023054.7
|
Apobec3
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
chr17_+_17316078 | 7.06 |
ENSMUST00000105311.3
|
Gm6712
|
predicted gene 6712 |
chr16_+_38362205 | 7.04 |
ENSMUST00000023494.6
|
Popdc2
|
popeye domain containing 2 |
chr7_-_103853199 | 6.99 |
ENSMUST00000033229.3
|
Hbb-y
|
hemoglobin Y, beta-like embryonic chain |
chr7_-_142666816 | 6.91 |
ENSMUST00000105935.1
|
Igf2
|
insulin-like growth factor 2 |
chr1_+_135799402 | 6.90 |
ENSMUST00000152208.1
ENSMUST00000152075.1 ENSMUST00000154463.1 ENSMUST00000139986.1 |
Tnni1
|
troponin I, skeletal, slow 1 |
chr6_+_34412334 | 6.89 |
ENSMUST00000007449.8
|
Akr1b7
|
aldo-keto reductase family 1, member B7 |
chr18_-_67549173 | 6.81 |
ENSMUST00000115050.1
|
Spire1
|
spire homolog 1 (Drosophila) |
chr12_+_109545390 | 6.78 |
ENSMUST00000146701.1
|
Meg3
|
maternally expressed 3 |
chr8_-_53638945 | 6.76 |
ENSMUST00000047768.4
|
Neil3
|
nei like 3 (E. coli) |
chr16_+_36156801 | 6.76 |
ENSMUST00000079184.4
|
Stfa2l1
|
stefin A2 like 1 |
chr7_-_103827922 | 6.73 |
ENSMUST00000023934.6
ENSMUST00000153218.1 |
Hbb-bs
|
hemoglobin, beta adult s chain |
chrX_+_8271642 | 6.62 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr1_+_164062070 | 6.50 |
ENSMUST00000097491.3
ENSMUST00000027871.7 |
Sell
|
selectin, lymphocyte |
chr11_-_87875524 | 6.47 |
ENSMUST00000049768.3
|
Epx
|
eosinophil peroxidase |
chr17_-_43502773 | 6.39 |
ENSMUST00000024707.8
ENSMUST00000117137.1 |
Mep1a
|
meprin 1 alpha |
chr8_-_85380964 | 6.22 |
ENSMUST00000122452.1
|
Mylk3
|
myosin light chain kinase 3 |
chr18_-_74207771 | 6.22 |
ENSMUST00000040188.8
ENSMUST00000177604.1 |
Ska1
|
spindle and kinetochore associated complex subunit 1 |
chr16_+_38362234 | 6.18 |
ENSMUST00000114739.1
|
Popdc2
|
popeye domain containing 2 |
chrX_-_8145713 | 6.18 |
ENSMUST00000115615.2
ENSMUST00000115616.1 ENSMUST00000115621.2 |
Rbm3
|
RNA binding motif protein 3 |
chr7_-_142576492 | 6.17 |
ENSMUST00000140716.1
|
H19
|
H19 fetal liver mRNA |
chr3_+_135212557 | 6.15 |
ENSMUST00000062893.7
|
Cenpe
|
centromere protein E |
chr11_+_44617310 | 6.14 |
ENSMUST00000081265.5
ENSMUST00000101326.3 ENSMUST00000109268.1 |
Ebf1
|
early B cell factor 1 |
chr6_+_134929118 | 6.13 |
ENSMUST00000185152.1
ENSMUST00000184504.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr16_-_36367623 | 6.09 |
ENSMUST00000096089.2
|
BC100530
|
cDNA sequence BC100530 |
chr4_-_154928545 | 6.06 |
ENSMUST00000152687.1
|
Tnfrsf14
|
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
chr4_+_123282778 | 6.01 |
ENSMUST00000106243.1
ENSMUST00000106241.1 ENSMUST00000080178.6 |
Pabpc4
|
poly(A) binding protein, cytoplasmic 4 |
chr11_+_69045640 | 6.00 |
ENSMUST00000108666.1
ENSMUST00000021277.5 |
Aurkb
|
aurora kinase B |
chr1_+_131638485 | 5.94 |
ENSMUST00000112411.1
|
Ctse
|
cathepsin E |
chr17_+_29114142 | 5.93 |
ENSMUST00000141797.1
ENSMUST00000132262.1 ENSMUST00000141239.1 ENSMUST00000138816.1 |
Gm16194
|
predicted gene 16194 |
chr4_+_108579445 | 5.93 |
ENSMUST00000102744.3
|
Orc1
|
origin recognition complex, subunit 1 |
chr11_-_6520894 | 5.88 |
ENSMUST00000003459.3
|
Myo1g
|
myosin IG |
chr16_+_37011758 | 5.85 |
ENSMUST00000071452.5
ENSMUST00000054034.6 |
Polq
|
polymerase (DNA directed), theta |
chr9_-_67832325 | 5.80 |
ENSMUST00000054500.5
|
C2cd4a
|
C2 calcium-dependent domain containing 4A |
chr4_+_34893772 | 5.79 |
ENSMUST00000029975.3
ENSMUST00000135871.1 ENSMUST00000108130.1 |
Cga
|
glycoprotein hormones, alpha subunit |
chr6_-_40999479 | 5.78 |
ENSMUST00000166306.1
|
Gm2663
|
predicted gene 2663 |
chr16_+_32756336 | 5.74 |
ENSMUST00000135753.1
|
Muc4
|
mucin 4 |
chr16_-_36455378 | 5.72 |
ENSMUST00000068182.2
|
Stfa3
|
stefin A3 |
chr1_-_149922339 | 5.69 |
ENSMUST00000111926.2
|
Pla2g4a
|
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr17_+_36869567 | 5.67 |
ENSMUST00000060524.9
|
Trim10
|
tripartite motif-containing 10 |
chr13_-_113100971 | 5.63 |
ENSMUST00000023897.5
|
Gzma
|
granzyme A |
chr2_+_84734050 | 5.57 |
ENSMUST00000090729.2
|
Ypel4
|
yippee-like 4 (Drosophila) |
chr1_-_71103146 | 5.56 |
ENSMUST00000027393.7
|
Bard1
|
BRCA1 associated RING domain 1 |
chr3_+_159495408 | 5.48 |
ENSMUST00000120272.1
ENSMUST00000029825.7 ENSMUST00000106041.2 |
Depdc1a
|
DEP domain containing 1a |
chr14_-_47411666 | 5.45 |
ENSMUST00000111778.3
|
Dlgap5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr16_-_75909272 | 5.43 |
ENSMUST00000114239.2
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
chr8_-_85365341 | 5.43 |
ENSMUST00000121972.1
|
Mylk3
|
myosin light chain kinase 3 |
chr14_-_47418407 | 5.37 |
ENSMUST00000043296.3
|
Dlgap5
|
discs, large (Drosophila) homolog-associated protein 5 |
chrX_-_102250775 | 5.34 |
ENSMUST00000130589.1
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr4_-_87806276 | 5.34 |
ENSMUST00000148059.1
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chrX_-_8145679 | 5.32 |
ENSMUST00000115619.1
ENSMUST00000115617.3 ENSMUST00000040010.3 |
Rbm3
|
RNA binding motif protein 3 |
chr14_-_70630149 | 5.31 |
ENSMUST00000022694.9
|
Dmtn
|
dematin actin binding protein |
chr3_+_51661209 | 5.29 |
ENSMUST00000161590.1
|
Mgst2
|
microsomal glutathione S-transferase 2 |
chr6_+_30723541 | 5.28 |
ENSMUST00000115127.1
|
Mest
|
mesoderm specific transcript |
chr3_-_98339921 | 5.21 |
ENSMUST00000065793.5
|
Phgdh
|
3-phosphoglycerate dehydrogenase |
chr16_-_36334330 | 5.21 |
ENSMUST00000114850.2
|
BC117090
|
cDNA sequence BC1179090 |
chrX_-_104671048 | 5.20 |
ENSMUST00000042070.5
|
Zdhhc15
|
zinc finger, DHHC domain containing 15 |
chrX_-_7978027 | 5.19 |
ENSMUST00000125418.1
|
Gata1
|
GATA binding protein 1 |
chr4_-_44710408 | 5.19 |
ENSMUST00000134968.2
ENSMUST00000173821.1 ENSMUST00000174319.1 ENSMUST00000173733.1 ENSMUST00000172866.1 ENSMUST00000165417.2 ENSMUST00000107825.2 ENSMUST00000102932.3 ENSMUST00000107827.2 ENSMUST00000107826.2 |
Pax5
|
paired box gene 5 |
chr1_-_132367879 | 5.15 |
ENSMUST00000142609.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr1_-_126492900 | 5.13 |
ENSMUST00000161954.1
|
Nckap5
|
NCK-associated protein 5 |
chr19_-_34166037 | 5.13 |
ENSMUST00000025686.7
|
Ankrd22
|
ankyrin repeat domain 22 |
chr1_-_132390301 | 5.13 |
ENSMUST00000132435.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr2_+_103969528 | 5.11 |
ENSMUST00000123437.1
ENSMUST00000163256.1 |
Lmo2
|
LIM domain only 2 |
chr13_+_49544443 | 5.10 |
ENSMUST00000177948.1
ENSMUST00000021820.6 |
Aspn
|
asporin |
chr1_+_40439627 | 5.10 |
ENSMUST00000097772.3
|
Il1rl1
|
interleukin 1 receptor-like 1 |
chr15_-_103252810 | 5.07 |
ENSMUST00000154510.1
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr4_-_87806296 | 5.06 |
ENSMUST00000126353.1
ENSMUST00000149357.1 |
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr14_-_20269162 | 5.05 |
ENSMUST00000024155.7
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr11_+_32286946 | 4.99 |
ENSMUST00000101387.3
|
Hbq1b
|
hemoglobin, theta 1B |
chr15_-_36879816 | 4.97 |
ENSMUST00000100713.2
|
Gm10384
|
predicted gene 10384 |
chr2_+_174450678 | 4.94 |
ENSMUST00000016399.5
|
Tubb1
|
tubulin, beta 1 class VI |
chr3_-_20242173 | 4.89 |
ENSMUST00000001921.1
|
Cpa3
|
carboxypeptidase A3, mast cell |
chr7_-_3502465 | 4.86 |
ENSMUST00000065703.7
|
Tarm1
|
T cell-interacting, activating receptor on myeloid cells 1 |
chr8_-_84176552 | 4.84 |
ENSMUST00000070102.5
|
Nanos3
|
nanos homolog 3 (Drosophila) |
chr7_-_116084635 | 4.83 |
ENSMUST00000111755.3
|
Gm4353
|
predicted gene 4353 |
chr1_-_44061936 | 4.83 |
ENSMUST00000168641.1
|
Gm8251
|
predicted gene 8251 |
chr16_-_92697315 | 4.78 |
ENSMUST00000168195.1
ENSMUST00000113956.3 |
Runx1
|
runt related transcription factor 1 |
chrX_-_134583114 | 4.78 |
ENSMUST00000113213.1
ENSMUST00000033617.6 |
Btk
|
Bruton agammaglobulinemia tyrosine kinase |
chr4_+_126556935 | 4.78 |
ENSMUST00000048391.8
|
Clspn
|
claspin |
chr17_-_35085609 | 4.78 |
ENSMUST00000038507.6
|
Ly6g6f
|
lymphocyte antigen 6 complex, locus G6F |
chrX_-_51146414 | 4.77 |
ENSMUST00000041495.7
|
Mbnl3
|
muscleblind-like 3 (Drosophila) |
chr14_-_87141114 | 4.77 |
ENSMUST00000168889.1
|
Diap3
|
diaphanous homolog 3 (Drosophila) |
chr1_+_173420567 | 4.74 |
ENSMUST00000173023.1
|
Aim2
|
absent in melanoma 2 |
chr1_+_134182404 | 4.73 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chrX_+_21484532 | 4.72 |
ENSMUST00000089188.2
|
Agtr2
|
angiotensin II receptor, type 2 |
chr15_-_76669811 | 4.71 |
ENSMUST00000037824.4
|
Foxh1
|
forkhead box H1 |
chr16_-_76022266 | 4.68 |
ENSMUST00000114240.1
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
chr9_+_98490522 | 4.64 |
ENSMUST00000035029.2
|
Rbp2
|
retinol binding protein 2, cellular |
chr4_-_119189949 | 4.64 |
ENSMUST00000124626.1
|
Ermap
|
erythroblast membrane-associated protein |
chr11_-_69605829 | 4.62 |
ENSMUST00000047889.6
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr18_+_36528145 | 4.61 |
ENSMUST00000074298.6
ENSMUST00000115694.2 |
Slc4a9
|
solute carrier family 4, sodium bicarbonate cotransporter, member 9 |
chr8_+_79028587 | 4.61 |
ENSMUST00000119254.1
|
Zfp827
|
zinc finger protein 827 |
chrX_+_164140447 | 4.60 |
ENSMUST00000073973.4
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr4_+_44300876 | 4.58 |
ENSMUST00000045607.5
|
Melk
|
maternal embryonic leucine zipper kinase |
chr17_+_5799491 | 4.56 |
ENSMUST00000181484.1
|
3300005D01Rik
|
RIKEN cDNA 3300005D01 gene |
chr11_+_87794206 | 4.56 |
ENSMUST00000121303.1
|
Mpo
|
myeloperoxidase |
chr4_-_92191749 | 4.54 |
ENSMUST00000123179.1
|
Gm12666
|
predicted gene 12666 |
chr13_-_23465872 | 4.54 |
ENSMUST00000041674.7
|
Btn1a1
|
butyrophilin, subfamily 1, member A1 |
chr1_+_131638306 | 4.53 |
ENSMUST00000073350.6
|
Ctse
|
cathepsin E |
chr13_-_4150628 | 4.50 |
ENSMUST00000110704.2
ENSMUST00000021635.7 |
Akr1c18
|
aldo-keto reductase family 1, member C18 |
chr18_-_23981555 | 4.48 |
ENSMUST00000115829.1
|
Zscan30
|
zinc finger and SCAN domain containing 30 |
chr17_-_23645264 | 4.47 |
ENSMUST00000024696.7
|
Mmp25
|
matrix metallopeptidase 25 |
chr8_+_13339656 | 4.47 |
ENSMUST00000170909.1
|
Tfdp1
|
transcription factor Dp 1 |
chr13_+_21717626 | 4.46 |
ENSMUST00000091754.2
|
Hist1h3h
|
histone cluster 1, H3h |
chr1_+_40084764 | 4.46 |
ENSMUST00000027243.7
|
Il1r2
|
interleukin 1 receptor, type II |
chrX_-_102157065 | 4.45 |
ENSMUST00000056904.2
|
Ercc6l
|
excision repair cross-complementing rodent repair deficiency complementation group 6 like |
chr3_+_51661167 | 4.44 |
ENSMUST00000099106.3
|
Mgst2
|
microsomal glutathione S-transferase 2 |
chr10_+_75943020 | 4.43 |
ENSMUST00000121151.1
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr11_-_102365111 | 4.43 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr10_+_119992916 | 4.43 |
ENSMUST00000105261.2
|
Grip1
|
glutamate receptor interacting protein 1 |
chr1_+_107511489 | 4.43 |
ENSMUST00000064916.2
|
Serpinb2
|
serine (or cysteine) peptidase inhibitor, clade B, member 2 |
chr3_-_137981523 | 4.43 |
ENSMUST00000136613.1
ENSMUST00000029806.6 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr2_+_84980458 | 4.42 |
ENSMUST00000028467.5
|
Prg2
|
proteoglycan 2, bone marrow |
chr3_-_100489324 | 4.39 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr3_-_152166230 | 4.36 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr7_-_3915501 | 4.35 |
ENSMUST00000038176.8
ENSMUST00000090689.4 |
Lilra6
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 |
chr11_-_102469839 | 4.34 |
ENSMUST00000103086.3
|
Itga2b
|
integrin alpha 2b |
chr4_-_119190005 | 4.34 |
ENSMUST00000138395.1
ENSMUST00000156746.1 |
Ermap
|
erythroblast membrane-associated protein |
chr7_+_43408187 | 4.33 |
ENSMUST00000005592.6
|
Siglecg
|
sialic acid binding Ig-like lectin G |
chr1_+_153749414 | 4.33 |
ENSMUST00000086209.3
|
Rnasel
|
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
chr14_-_65833963 | 4.33 |
ENSMUST00000022613.9
|
Esco2
|
establishment of cohesion 1 homolog 2 (S. cerevisiae) |
chr10_+_115817247 | 4.33 |
ENSMUST00000035563.7
ENSMUST00000080630.3 ENSMUST00000179196.1 |
Tspan8
|
tetraspanin 8 |
chr3_-_98859774 | 4.32 |
ENSMUST00000107016.3
ENSMUST00000149768.1 |
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
chr5_+_90772435 | 4.32 |
ENSMUST00000031320.6
|
Pf4
|
platelet factor 4 |
chr11_+_87755567 | 4.31 |
ENSMUST00000123700.1
|
A430104N18Rik
|
RIKEN cDNA A430104N18 gene |
chr9_+_124102110 | 4.31 |
ENSMUST00000168841.1
ENSMUST00000055918.6 |
Ccr2
|
chemokine (C-C motif) receptor 2 |
chr2_-_165400398 | 4.30 |
ENSMUST00000029213.4
|
Ocstamp
|
osteoclast stimulatory transmembrane protein |
chr1_-_45503282 | 4.29 |
ENSMUST00000086430.4
|
Col5a2
|
collagen, type V, alpha 2 |
chr1_+_40439767 | 4.29 |
ENSMUST00000173514.1
|
Il1rl1
|
interleukin 1 receptor-like 1 |
chr10_+_3973086 | 4.27 |
ENSMUST00000117291.1
ENSMUST00000120585.1 ENSMUST00000043735.7 |
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr11_+_102248842 | 4.26 |
ENSMUST00000100392.4
|
BC030867
|
cDNA sequence BC030867 |
chr16_-_22161450 | 4.25 |
ENSMUST00000115379.1
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr7_+_24777172 | 4.24 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr2_+_118813995 | 4.21 |
ENSMUST00000134661.1
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding |
chr10_+_100015817 | 4.19 |
ENSMUST00000130190.1
ENSMUST00000020129.7 |
Kitl
|
kit ligand |
chr6_-_129913166 | 4.19 |
ENSMUST00000169901.2
ENSMUST00000167079.2 ENSMUST00000014683.6 |
Klra5
|
killer cell lectin-like receptor, subfamily A, member 5 |
chr7_+_43351378 | 4.14 |
ENSMUST00000012798.7
ENSMUST00000122423.1 ENSMUST00000121494.1 |
Siglec5
|
sialic acid binding Ig-like lectin 5 |
chr14_-_51057242 | 4.13 |
ENSMUST00000089798.2
|
Rnase12
|
ribonuclease, RNase A family, 12 (non-active) |
chr1_+_174158722 | 4.10 |
ENSMUST00000068403.3
|
Olfr420
|
olfactory receptor 420 |
chr1_-_58504946 | 4.09 |
ENSMUST00000027198.5
|
Orc2
|
origin recognition complex, subunit 2 |
chr1_+_153751946 | 4.09 |
ENSMUST00000183241.1
|
Rnasel
|
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
chr7_+_67952817 | 4.08 |
ENSMUST00000005671.8
|
Igf1r
|
insulin-like growth factor I receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 22.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
5.9 | 17.6 | GO:0030221 | basophil differentiation(GO:0030221) |
5.1 | 5.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
4.7 | 14.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
4.5 | 4.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
4.4 | 17.6 | GO:0036233 | glycine import(GO:0036233) |
4.4 | 13.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.0 | 12.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
3.7 | 11.1 | GO:0002215 | defense response to nematode(GO:0002215) |
3.4 | 10.2 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
3.4 | 20.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
3.3 | 9.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
3.2 | 9.7 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
3.0 | 8.9 | GO:0036292 | DNA rewinding(GO:0036292) |
2.9 | 23.3 | GO:0015671 | oxygen transport(GO:0015671) |
2.8 | 11.3 | GO:0045575 | basophil activation(GO:0045575) |
2.6 | 15.8 | GO:0031133 | regulation of axon diameter(GO:0031133) |
2.6 | 7.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
2.6 | 7.7 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
2.5 | 10.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
2.4 | 9.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.4 | 7.2 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
2.3 | 6.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.3 | 18.0 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
2.2 | 6.6 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
2.2 | 17.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.1 | 4.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
2.0 | 8.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
2.0 | 16.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.0 | 9.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
2.0 | 5.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.9 | 3.8 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
1.8 | 5.5 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
1.8 | 12.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.8 | 10.8 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.8 | 24.8 | GO:0015816 | glycine transport(GO:0015816) |
1.7 | 13.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.7 | 3.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
1.6 | 4.9 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.6 | 6.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.5 | 6.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.5 | 6.2 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
1.5 | 1.5 | GO:1905204 | negative regulation of connective tissue replacement(GO:1905204) |
1.5 | 7.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.5 | 4.4 | GO:2001188 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
1.5 | 8.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.4 | 4.3 | GO:0045004 | DNA replication proofreading(GO:0045004) |
1.4 | 8.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.4 | 4.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.4 | 7.0 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.4 | 4.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.4 | 2.8 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
1.3 | 2.7 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.3 | 8.0 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
1.3 | 11.9 | GO:0071231 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
1.3 | 10.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.3 | 2.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
1.3 | 1.3 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
1.3 | 3.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.3 | 3.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
1.3 | 3.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.3 | 6.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.3 | 3.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.3 | 1.3 | GO:0006272 | leading strand elongation(GO:0006272) |
1.2 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.2 | 3.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.2 | 3.6 | GO:0015811 | L-cystine transport(GO:0015811) |
1.2 | 4.8 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.2 | 9.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.2 | 2.4 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
1.2 | 3.5 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.2 | 2.4 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.2 | 51.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.2 | 1.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
1.2 | 4.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.2 | 3.5 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
1.2 | 4.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.1 | 5.7 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
1.1 | 3.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.1 | 1.1 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
1.1 | 3.4 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.1 | 3.4 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
1.1 | 9.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.1 | 6.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.1 | 3.3 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.1 | 4.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.1 | 8.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.1 | 2.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.1 | 5.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.1 | 3.2 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
1.1 | 14.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.0 | 4.2 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
1.0 | 4.1 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.0 | 2.0 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
1.0 | 11.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.0 | 5.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.0 | 3.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.0 | 1.0 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
1.0 | 4.0 | GO:0042223 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
1.0 | 12.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.0 | 3.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.0 | 4.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.9 | 3.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.9 | 2.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.9 | 2.8 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.9 | 14.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.9 | 3.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.9 | 2.7 | GO:1990523 | bone regeneration(GO:1990523) |
0.9 | 4.5 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.9 | 3.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.9 | 11.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.9 | 3.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 8.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 2.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.9 | 4.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.9 | 3.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.9 | 9.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.9 | 2.6 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.8 | 3.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.8 | 2.5 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.8 | 1.7 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.8 | 9.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.8 | 7.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.8 | 12.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.8 | 3.3 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 5.7 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.8 | 4.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.8 | 3.3 | GO:0060032 | notochord regression(GO:0060032) |
0.8 | 15.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.8 | 4.0 | GO:0030421 | defecation(GO:0030421) |
0.8 | 0.8 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.8 | 3.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.8 | 7.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.8 | 3.2 | GO:0033377 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.8 | 7.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.8 | 2.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.8 | 4.7 | GO:0001927 | exocyst assembly(GO:0001927) |
0.8 | 2.3 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.8 | 3.1 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.8 | 3.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.8 | 3.1 | GO:0046722 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.8 | 8.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.8 | 2.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.8 | 2.3 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.7 | 2.2 | GO:0009644 | response to high light intensity(GO:0009644) |
0.7 | 6.7 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.7 | 5.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 3.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.7 | 1.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.7 | 2.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.7 | 4.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 2.2 | GO:1904732 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.7 | 5.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.7 | 4.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.7 | 2.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.7 | 5.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.7 | 3.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 0.7 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.7 | 2.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.7 | 0.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.7 | 4.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 1.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.7 | 3.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.7 | 2.1 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.7 | 0.7 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.7 | 5.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.7 | 2.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.7 | 10.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.7 | 2.1 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.7 | 0.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.7 | 6.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.7 | 5.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.7 | 7.5 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.7 | 2.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.7 | 1.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.7 | 3.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.7 | 2.0 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.7 | 2.7 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.7 | 2.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.7 | 5.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.7 | 2.0 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.7 | 2.7 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.7 | 7.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.7 | 0.7 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
0.7 | 2.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.6 | 2.6 | GO:0098953 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.6 | 5.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 8.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.6 | 2.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 1.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 2.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.6 | 5.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.6 | 1.9 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.6 | 1.8 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.6 | 10.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.6 | 0.6 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.6 | 1.8 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.6 | 2.4 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.6 | 9.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 4.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 2.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.6 | 4.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 7.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 6.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.6 | 1.2 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.6 | 3.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.6 | 2.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.6 | 3.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 2.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.6 | 1.8 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.6 | 4.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 1.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 1.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 7.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 1.8 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.6 | 1.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 1.8 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.6 | 7.0 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.6 | 0.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.6 | 4.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.6 | 27.0 | GO:0009409 | response to cold(GO:0009409) |
0.6 | 3.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 0.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.6 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.6 | 1.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.6 | 0.6 | GO:0036269 | swimming behavior(GO:0036269) |
0.6 | 9.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.6 | 2.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 2.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 3.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.5 | 4.4 | GO:0060022 | hard palate development(GO:0060022) |
0.5 | 4.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 1.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.5 | 2.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 2.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.5 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 2.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 7.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.5 | 13.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.5 | 1.1 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.5 | 9.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.5 | 7.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 1.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.5 | 1.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.5 | 4.7 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.5 | 3.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 5.7 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.5 | 7.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 1.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.5 | 2.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 1.5 | GO:0050929 | corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.5 | 6.6 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.5 | 1.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.5 | 2.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 4.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 0.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.5 | 1.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 3.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 1.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.5 | 2.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.5 | 2.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 0.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.5 | 0.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.5 | 4.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.5 | 3.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.5 | 1.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 2.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.5 | 4.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.5 | 3.0 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.5 | 1.5 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.5 | 2.4 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 2.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 2.9 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.5 | 0.5 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.5 | 0.5 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.5 | 3.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 8.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 1.4 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.5 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 1.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 2.9 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 1.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 2.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 1.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.5 | 7.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 12.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 1.4 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.5 | 0.9 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.5 | 1.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 1.4 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.5 | 5.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.5 | 1.8 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.5 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 0.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 1.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 1.8 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 1.3 | GO:0071846 | actin filament debranching(GO:0071846) |
0.4 | 7.6 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.4 | 0.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 3.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.4 | 3.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.9 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 1.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
0.4 | 2.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 10.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 0.9 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 6.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 3.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.4 | 4.8 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 0.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.4 | 9.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.4 | 9.5 | GO:0030220 | platelet formation(GO:0030220) |
0.4 | 4.7 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.4 | 1.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.4 | 5.5 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.4 | 0.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.4 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 2.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 2.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 1.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 1.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 1.2 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.4 | 8.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.4 | 2.0 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 1.6 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.4 | 2.8 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.4 | 0.8 | GO:0072275 | metanephric glomerulus vasculature development(GO:0072239) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.4 | 3.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 3.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 0.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 2.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 2.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 1.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 0.8 | GO:0003195 | tricuspid valve formation(GO:0003195) |
0.4 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 2.3 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 2.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 0.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.4 | 1.5 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.4 | 7.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 1.2 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.4 | 0.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.4 | 1.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.4 | 6.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 10.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.4 | 1.1 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.4 | 3.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 0.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.4 | 1.1 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.4 | 3.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 1.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 1.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 2.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.4 | 3.6 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 1.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 3.3 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.4 | 1.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 4.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.4 | 1.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.4 | 1.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 2.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.4 | 2.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.4 | 2.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 2.8 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.4 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 1.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.4 | 1.1 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
0.3 | 4.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.3 | 1.4 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.3 | 1.0 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
0.3 | 1.0 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.3 | 1.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 1.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.3 | 1.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.3 | 0.3 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 0.3 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.3 | 1.0 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.3 | 2.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 1.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.7 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.3 | 3.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 1.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 4.3 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.3 | 0.7 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.3 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.3 | 0.7 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.3 | 3.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.3 | 5.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 1.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 6.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 1.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 4.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.3 | 3.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 10.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 1.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.6 | GO:0072054 | renal outer medulla development(GO:0072054) |
0.3 | 0.3 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.3 | 1.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 5.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 5.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.3 | 1.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 2.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 2.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.9 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.3 | 2.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 0.9 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.3 | 6.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 1.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 2.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 1.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 1.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 15.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 2.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.3 | 9.3 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.3 | 2.4 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 0.9 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.3 | 2.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 5.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 3.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 2.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 1.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 19.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 2.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 5.5 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 4.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 2.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.6 | GO:0032470 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.3 | 9.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 5.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.3 | 0.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 0.8 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.3 | 1.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.8 | GO:0044849 | estrous cycle(GO:0044849) |
0.3 | 1.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.8 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.3 | 1.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 8.9 | GO:0061515 | myeloid cell development(GO:0061515) |
0.3 | 4.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 1.9 | GO:0050716 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.3 | 0.8 | GO:0046144 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.3 | 4.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.3 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 1.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.3 | 1.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.3 | 5.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 0.8 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.3 | 0.3 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.3 | 1.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 0.3 | GO:0099548 | trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
0.3 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 0.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.3 | 0.8 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.5 | GO:0060028 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) convergent extension involved in axis elongation(GO:0060028) mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.3 | 1.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 1.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 5.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.3 | 2.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.3 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) apoptotic process involved in heart morphogenesis(GO:0003278) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.3 | 1.0 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 4.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 1.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 0.3 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.3 | 4.8 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.3 | 0.3 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.3 | 0.3 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.2 | 1.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 1.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 1.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 0.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 2.0 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 1.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 1.0 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.2 | 8.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.2 | 1.0 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.2 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.2 | 1.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.5 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 0.5 | GO:0072717 | response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
0.2 | 1.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.5 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.2 | 1.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 4.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.5 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.2 | 1.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 3.9 | GO:0045191 | regulation of isotype switching(GO:0045191) |
0.2 | 2.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 7.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.7 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.2 | 6.7 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.2 | 5.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 3.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 1.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 2.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 2.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 1.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 2.5 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.2 | 1.6 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.7 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.2 | 2.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 7.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 1.8 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.2 | 1.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 1.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 1.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 1.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 1.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.6 | GO:0010935 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
0.2 | 0.4 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 1.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 4.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 3.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 0.6 | GO:1904008 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
0.2 | 1.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 2.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.8 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.2 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 1.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 1.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.2 | 5.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 8.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.2 | 1.4 | GO:0045589 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 0.2 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 21.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 3.5 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 5.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 0.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.6 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 0.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 2.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.9 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 3.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 1.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 2.2 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.5 | GO:2000584 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.2 | 0.5 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 1.3 | GO:0071514 | genetic imprinting(GO:0071514) |
0.2 | 0.7 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.2 | 1.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.5 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.9 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 2.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.4 | GO:0060433 | bronchus development(GO:0060433) |
0.2 | 1.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 5.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.2 | 0.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.2 | 0.3 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.2 | 2.4 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.2 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 1.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 2.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 1.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 3.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 3.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 6.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 1.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.5 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 2.1 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.2 | 1.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.5 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 3.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.5 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.2 | 0.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.5 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 0.3 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 4.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.6 | GO:0003093 | regulation of glomerular filtration(GO:0003093) negative regulation of glomerular filtration(GO:0003105) |
0.2 | 1.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 2.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.5 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.2 | 1.4 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 0.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 0.8 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.2 | 0.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 0.8 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.2 | 0.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.5 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.3 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 3.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 2.1 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.9 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 1.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.5 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 3.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.7 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.1 | 0.7 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 7.3 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.1 | 0.6 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.6 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 1.9 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 1.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 5.5 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.6 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 0.4 | GO:0071692 | sequestering of BMP in extracellular matrix(GO:0035582) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.1 | 2.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.1 | GO:0072075 | metanephric mesenchyme development(GO:0072075) |
0.1 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 2.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 3.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 1.6 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.3 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.1 | 0.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.9 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 0.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.4 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 6.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 1.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 2.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 5.4 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.7 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.2 | GO:0071372 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 1.3 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.5 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.4 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.6 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 1.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.1 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 0.1 | GO:0042148 | meiotic DNA recombinase assembly(GO:0000707) strand invasion(GO:0042148) |
0.1 | 0.2 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.5 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 1.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 1.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.0 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.1 | 1.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 5.3 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.5 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 1.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.1 | 0.1 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.3 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.8 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 1.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 1.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 2.6 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.1 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 1.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 4.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.3 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.6 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 3.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.3 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 2.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.2 | GO:1902915 | histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.5 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 3.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.5 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.2 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.1 | 1.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 2.0 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 1.9 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.2 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.5 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.2 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.1 | 0.4 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 3.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 2.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.8 | GO:0009309 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.1 | 0.7 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0015870 | acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) acetate ester transport(GO:1901374) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.1 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.1 | 0.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.2 | GO:0097531 | mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
0.1 | 0.1 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.5 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.1 | 0.4 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 1.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0031591 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 | 1.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 1.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.7 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.6 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:1903003 | regulation of protein deubiquitination(GO:0090085) positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.1 | 0.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.4 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 1.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 1.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.4 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.0 | 0.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.0 | 0.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 1.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.3 | GO:0070203 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) |
0.0 | 0.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.0 | GO:1902074 | response to salt(GO:1902074) |
0.0 | 0.6 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 1.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 1.4 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.0 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.4 | GO:0043476 | pigment accumulation(GO:0043476) |
0.0 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
0.0 | 0.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.0 | 0.2 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.0 | 0.1 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 1.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.0 | 0.1 | GO:0031109 | microtubule polymerization or depolymerization(GO:0031109) |
0.0 | 0.2 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.4 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.0 | 0.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.5 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.0 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.0 | 0.1 | GO:0046707 | ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.1 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 0.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 37.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.0 | 18.3 | GO:0032437 | cuticular plate(GO:0032437) |
2.4 | 9.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
2.3 | 9.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.2 | 2.2 | GO:0030056 | hemidesmosome(GO:0030056) |
2.1 | 6.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.9 | 3.8 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
1.8 | 7.3 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
1.8 | 22.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.8 | 10.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.6 | 4.9 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
1.6 | 4.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.4 | 15.9 | GO:0042629 | mast cell granule(GO:0042629) |
1.4 | 7.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.4 | 4.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.4 | 11.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.3 | 4.0 | GO:1990423 | RZZ complex(GO:1990423) |
1.3 | 24.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 7.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.2 | 6.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.1 | 4.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.1 | 17.9 | GO:0042581 | specific granule(GO:0042581) |
1.1 | 5.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.1 | 4.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 6.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.0 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.9 | 5.6 | GO:0098536 | deuterosome(GO:0098536) |
0.9 | 0.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.9 | 16.6 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 9.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 0.9 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.9 | 4.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.9 | 4.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 3.2 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.8 | 0.8 | GO:0044753 | amphisome(GO:0044753) |
0.8 | 4.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.8 | 5.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.8 | 10.9 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 3.0 | GO:0008623 | CHRAC(GO:0008623) |
0.7 | 5.2 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 2.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 2.0 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.7 | 3.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 4.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 2.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 11.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 1.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.6 | 1.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 2.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 3.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 2.4 | GO:0090537 | CERF complex(GO:0090537) |
0.6 | 1.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.6 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.6 | 13.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 1.7 | GO:0014802 | terminal cisterna(GO:0014802) |
0.6 | 8.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.6 | 5.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 4.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.6 | 1.7 | GO:0071920 | cleavage body(GO:0071920) |
0.6 | 6.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 3.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 8.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 5.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 2.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 1.1 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 1.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 13.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 5.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 1.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 4.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 2.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 2.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.5 | 7.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.3 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 0.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.5 | 1.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 4.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 3.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 1.3 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.4 | 4.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 12.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 4.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 1.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 0.4 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 11.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 12.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 1.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 1.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.4 | 45.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 1.1 | GO:0031251 | PAN complex(GO:0031251) |
0.4 | 8.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 6.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.4 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 1.9 | GO:0071914 | prominosome(GO:0071914) |
0.4 | 4.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 4.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 17.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 2.1 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 1.1 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 8.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 3.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 2.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 9.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 12.4 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 5.3 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 2.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 12.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 3.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 3.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 6.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 25.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 2.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 1.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.3 | 5.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 4.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 2.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 0.9 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.3 | 0.9 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 1.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 1.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 10.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 0.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 3.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 0.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 8.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 2.7 | GO:0002177 | manchette(GO:0002177) |
0.3 | 1.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.3 | 2.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 1.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 0.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 2.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 8.2 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 3.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 27.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 8.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 2.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 20.2 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.3 | 17.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 0.8 | GO:1990047 | spindle matrix(GO:1990047) |
0.3 | 2.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.2 | 8.5 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 5.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 1.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 12.6 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 0.7 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 8.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 1.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 5.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 0.5 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 10.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 8.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 5.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 2.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.2 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.2 | 19.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.2 | 1.7 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 2.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 1.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.3 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 2.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 4.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 3.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.6 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 16.6 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 1.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 2.3 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 3.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.6 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.2 | 2.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.5 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 4.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 3.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 2.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 11.7 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 8.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 2.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 1.8 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.2 | 9.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 3.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 2.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 6.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 1.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 1.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 3.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 5.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 6.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 1.7 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 3.9 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.5 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.6 | GO:0044301 | climbing fiber(GO:0044301) |
0.1 | 2.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 5.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.7 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 3.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 8.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 3.3 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 3.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 4.1 | GO:0005819 | spindle(GO:0005819) |
0.1 | 13.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.3 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 1.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 2.3 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 4.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 2.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 6.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 31.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 2.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 5.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 10.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 4.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 5.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 2.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 5.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.4 | GO:0031430 | M band(GO:0031430) |
0.1 | 21.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 2.3 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.8 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.9 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 3.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 7.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 7.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 3.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 2.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 2.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.2 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 6.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 17.4 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 2.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 8.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 4.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 4.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 25.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
5.4 | 16.2 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
4.1 | 16.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
3.3 | 9.9 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
3.1 | 9.4 | GO:0002113 | interleukin-33 binding(GO:0002113) |
3.0 | 9.1 | GO:0045159 | myosin II binding(GO:0045159) |
2.7 | 19.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.6 | 5.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.5 | 9.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.4 | 9.7 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
2.4 | 26.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.4 | 19.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.3 | 23.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.1 | 10.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
1.9 | 5.7 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
1.9 | 11.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.9 | 11.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.8 | 7.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.8 | 9.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.8 | 14.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.8 | 5.5 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
1.8 | 5.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.8 | 12.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.8 | 12.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
1.8 | 5.3 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.7 | 6.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.7 | 8.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.5 | 6.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
1.5 | 7.7 | GO:0043515 | kinetochore binding(GO:0043515) |
1.5 | 4.5 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
1.4 | 21.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.4 | 8.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.4 | 5.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.3 | 4.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.3 | 5.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.3 | 6.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.3 | 3.8 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
1.2 | 3.7 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
1.2 | 3.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.2 | 10.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.2 | 3.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
1.2 | 4.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 3.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.0 | 4.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.0 | 8.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.0 | 5.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.0 | 5.1 | GO:0043532 | angiostatin binding(GO:0043532) |
1.0 | 10.9 | GO:0051870 | methotrexate binding(GO:0051870) |
1.0 | 4.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.0 | 3.9 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.9 | 13.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.9 | 2.8 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.9 | 0.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.9 | 3.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.9 | 2.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.9 | 1.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 3.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.8 | 2.5 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.8 | 3.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.8 | 7.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 6.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 2.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.8 | 21.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.8 | 2.4 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
0.8 | 0.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.8 | 3.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.8 | 5.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.8 | 0.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.8 | 4.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.8 | 7.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 2.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.7 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 4.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 3.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.7 | 5.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.7 | 2.0 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.7 | 2.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 5.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.7 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 3.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 1.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 5.7 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 6.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.6 | 1.9 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.6 | 1.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 1.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 1.8 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.6 | 1.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.6 | 16.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 3.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.6 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 3.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 3.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 1.8 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.6 | 8.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 8.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.6 | 17.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 11.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 1.7 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.6 | 4.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 2.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 1.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.6 | 8.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 2.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.6 | 1.7 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.6 | 3.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 2.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.5 | 18.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 2.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.5 | 1.6 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.5 | 4.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.5 | 12.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 1.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.5 | 2.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.5 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 16.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 7.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 1.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.5 | 3.0 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.5 | 1.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 3.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 3.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 2.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.5 | 1.5 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.5 | 1.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 2.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 12.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 5.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 12.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 0.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 7.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 1.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.5 | 1.4 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.5 | 5.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 37.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 1.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.5 | 9.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 2.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.4 | 2.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 3.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 10.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 1.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.4 | 8.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 3.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 10.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 2.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 1.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 1.2 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.4 | 12.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 2.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 4.5 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 2.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 3.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 2.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 2.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 22.5 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 3.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 2.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.4 | 1.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 1.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 1.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.4 | 5.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 2.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 2.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 0.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 1.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.4 | 15.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 0.7 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.4 | 1.9 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.4 | 3.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 1.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.4 | 1.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.4 | 1.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 3.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 10.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.4 | 1.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 2.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.4 | 2.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 2.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 1.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.4 | 7.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 5.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 1.0 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.3 | 1.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 1.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 14.5 | GO:0030546 | receptor activator activity(GO:0030546) |
0.3 | 1.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 1.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.3 | 1.4 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.3 | 2.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 12.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.7 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.3 | 2.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 4.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 3.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 2.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 16.7 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 17.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 2.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 2.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 8.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 1.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 1.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 0.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 1.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 1.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.3 | 0.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.3 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 3.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 1.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.3 | 3.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 3.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 1.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 0.9 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.3 | 5.7 | GO:0051861 | glycolipid binding(GO:0051861) |
0.3 | 1.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 15.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 34.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 0.9 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.3 | 4.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.3 | 0.6 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.3 | 1.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 12.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 6.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 9.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.8 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.3 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 2.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 3.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.9 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.3 | 0.8 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.3 | 1.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 10.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 0.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.3 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 3.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 1.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 8.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.8 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.3 | 1.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.0 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.2 | 2.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 3.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 1.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 4.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 3.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 0.7 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.2 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 6.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 2.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 3.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 14.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 2.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.2 | 6.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 9.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.6 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 3.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.8 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.2 | 1.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 5.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 1.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 1.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.8 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 1.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 2.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 1.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 4.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 2.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.6 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.2 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.2 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
0.2 | 1.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.5 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 8.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 3.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 4.8 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 8.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 11.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 2.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.7 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.2 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 3.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 3.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.8 | GO:0034595 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.2 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 2.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 2.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.8 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 3.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.6 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.2 | 0.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 1.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.5 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 0.5 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 2.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 5.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 6.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 3.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 1.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 8.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 5.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.5 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 2.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 3.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 1.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 2.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 5.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 3.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 3.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 17.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 8.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 8.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 3.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 6.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.8 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 4.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 1.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 2.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 1.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 2.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 5.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 2.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.3 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 4.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.4 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 8.1 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 7.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.2 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 3.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.1 | GO:0070540 | stearic acid binding(GO:0070540) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.6 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 23.7 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 2.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 2.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 2.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 2.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.1 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 3.5 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 1.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.3 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 7.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.0 | 1.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 5.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.1 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 1.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 13.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.0 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 8.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.8 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 51.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.8 | 13.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.7 | 10.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 4.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 24.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.6 | 3.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 42.3 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 18.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 13.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 19.2 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 8.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 16.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 16.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 58.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 2.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 17.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 9.0 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 13.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 4.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 11.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 4.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 10.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 10.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 13.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 21.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 5.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 4.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 1.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 5.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 6.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 4.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 3.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 4.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 5.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 6.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 5.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 40.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 7.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 5.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 2.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 6.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 7.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 2.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 2.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 5.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 6.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 2.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 5.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 4.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 7.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 3.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 10.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 2.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 3.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 6.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 5.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 4.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 3.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 4.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 2.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 5.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 14.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 9.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 14.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.3 | 7.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.2 | 5.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.1 | 5.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.0 | 20.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.0 | 43.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 44.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.9 | 18.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.9 | 13.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 7.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.9 | 8.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.8 | 5.7 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.8 | 84.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 19.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.7 | 10.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 2.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.6 | 6.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.6 | 8.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 7.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.5 | 28.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 14.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 3.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 11.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 7.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 7.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 10.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 5.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 19.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 11.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 8.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 22.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 10.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 7.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 5.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 3.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 4.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 8.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 6.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 23.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 2.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 13.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 4.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 2.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 34.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 6.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 7.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 3.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 23.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 3.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 2.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 0.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 3.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 2.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 4.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 1.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 11.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 5.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 1.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 3.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 22.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 17.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 4.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 1.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 1.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 7.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 11.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 10.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 4.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 5.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 1.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 5.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 2.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 3.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 8.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.2 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.2 | 1.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 0.8 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 4.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 3.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 3.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 3.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 2.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 6.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 4.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 4.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 17.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 3.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 14.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 1.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 1.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 22.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 3.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 2.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 5.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 3.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 15.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 4.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 2.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 1.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 3.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 7.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 5.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 1.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 3.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.4 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 2.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 1.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 1.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |